Hyperprogression under immunotherapy: a new form of immunotherapy response?—a narrative literature review

OBJECTIVE: Update the last known review, and summarize the definitions, diagnostic criteria, reported risk factors, possible mechanisms and potential biomarkers of hyperprogressive disease (HPD) under immunotherapy. BACKGROUND: Immunotherapy is a relatively new systemic therapy adding a new method o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Miaozhen, Vanneste, Ben G. L., Yu, Qiwen, Chen, Zebin, Peng, Jiayu, Cai, Xiuyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350090/
https://www.ncbi.nlm.nih.gov/pubmed/34430364
http://dx.doi.org/10.21037/tlcr-21-575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350090/
https://www.ncbi.nlm.nih.gov/pubmed/34430364
http://dx.doi.org/10.21037/tlcr-21-575

Ejemplares similares